HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sharlene Gill Selected Research
Sharlene Gill Research Topics
Disease
32
Neoplasms (Cancer)
10/2022 - 05/2003
27
Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2004
20
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2003
11
Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 05/2009
8
Adenocarcinoma
04/2021 - 05/2006
5
Hepatocellular Carcinoma (Hepatoma)
11/2020 - 06/2008
2
Microsatellite Instability
10/2022 - 09/2005
2
Hypertension (High Blood Pressure)
01/2019 - 01/2013
2
Carcinoma (Carcinomatosis)
12/2018 - 02/2005
2
Neoplasm Metastasis (Metastasis)
12/2018 - 01/2004
2
Fatigue
01/2018 - 01/2013
2
Hepatitis B
08/2014 - 01/2013
2
Diarrhea
01/2013 - 06/2008
2
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2005 - 01/2004
1
Turcot syndrome
10/2022
1
Peripheral Nervous System Diseases (PNS Diseases)
10/2022
1
COVID-19
01/2022
1
Lymphatic Metastasis
10/2021
1
Asymptomatic Diseases
04/2021
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020
1
Brain Diseases (Brain Disorder)
12/2018
1
Lactic Acidosis
12/2018
1
Anorexia
01/2018
1
Nausea
01/2018
1
Dehydration (Water Stress)
01/2018
1
Abdominal Pain (Pain, Abdominal)
01/2018
1
Diabetes Mellitus
12/2016
1
Neutropenia
12/2014
1
Febrile Neutropenia
12/2014
1
Infections
08/2014
1
Obesity
06/2013
1
Abdominal Neoplasms (Abdominal Neoplasm)
04/2009
1
Agranulocytosis (Granulocytopenia)
06/2008
1
Leukopenia
06/2008
Drug/Important Bio-Agent (IBA)
18
Fluorouracil (Carac)
FDA Link
Generic
10/2022 - 05/2004
17
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2022 - 01/2004
9
Leucovorin (Folinic Acid)
FDA Link
10/2022 - 05/2004
7
Gemcitabine
FDA Link
12/2019 - 05/2009
6
Capecitabine (Xeloda)
FDA Link
10/2022 - 11/2005
4
folfirinox
IBA
12/2019 - 10/2017
4
Irinotecan (Camptosar)
FDA Link
Generic
11/2016 - 01/2004
3
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2016
3
Cetuximab (Erbitux)
FDA Link
12/2016 - 04/2012
3
Enterotoxin Receptors
IBA
06/2015 - 11/2011
3
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
02/2005 - 10/2003
2
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 10/2003
2
Phosphotransferases (Kinase)
IBA
08/2019 - 07/2013
2
Messenger RNA (mRNA)
IBA
08/2014 - 11/2011
2
Sorafenib (BAY 43-9006)
FDA Link
08/2014 - 07/2013
2
Bevacizumab (Avastin)
FDA Link
06/2011 - 05/2009
2
Celecoxib (Celebrex)
FDA Link
02/2005 - 01/2004
2
Sulindac (Copal)
FDA Link
Generic
02/2005 - 01/2004
2
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
02/2005 - 01/2004
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2005 - 01/2004
1
Antibodies
IBA
01/2022
1
hydroxide ion
IBA
10/2021
1
25-hydroxyvitamin D
IBA
10/2021
1
Vitamin D
FDA Link
Generic
10/2021
1
Adiponectin
IBA
10/2021
1
larotrectinib
IBA
01/2021
1
entrectinib
IBA
01/2021
1
Calcibiotic Root Canal Sealer
IBA
01/2020
1
Circulating Tumor DNA
IBA
01/2020
1
Yttrium-90
IBA
01/2020
1
Neuregulin-1 (Neuregulin 1)
IBA
08/2019
1
Ligands
IBA
08/2019
1
Afatinib
IBA
08/2019
1
regorafenib
IBA
01/2019
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2019
1
Perindopril
FDA Link
Generic
01/2019
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2019
1
Lactic Acid (Lactate)
FDA Link
Generic
12/2018
1
Sirtuins
IBA
05/2018
1
napabucasin
IBA
01/2018
1
130-nm albumin-bound paclitaxel
IBA
10/2017
1
Metformin (Glucophage)
FDA Link
Generic
12/2016
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2016
1
Biological Products
IBA
06/2014
1
linifanib
IBA
01/2013
1
saracatinib
IBA
04/2012
1
Formaldehyde (Formol)
FDA Link
11/2011
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2009
1
Mucins
IBA
04/2009
1
ispinesib
IBA
06/2008
1
Transaminases (Aminotransferases)
IBA
06/2008
1
raltitrexed (D 1694)
IBA
12/2007
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2007
1
Epidermal Growth Factor (EGF)
IBA
01/2007
Therapy/Procedure
33
Therapeutics
10/2022 - 05/2003
23
Drug Therapy (Chemotherapy)
10/2022 - 05/2003
12
Adjuvant Chemotherapy
10/2022 - 02/2010
4
Radiotherapy
01/2020 - 05/2003
3
Duration of Therapy
01/2019 - 02/2005
2
Continuity of Patient Care
01/2022 - 10/2020
2
Biological Therapy
12/2014 - 01/2007
1
Precision Medicine
01/2022
1
Metastasectomy
01/2020
1
Renal Dialysis (Hemodialysis)
12/2018
1
Microspheres (Microsphere)
05/2018
1
Folfox protocol
04/2012